IL40686A - 2-amino-imidazo(5,1-f)-as-triazin-4(3h)-ones,their preparation and pharmaceutical compositions containing them - Google Patents

2-amino-imidazo(5,1-f)-as-triazin-4(3h)-ones,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL40686A
IL40686A IL40686A IL4068672A IL40686A IL 40686 A IL40686 A IL 40686A IL 40686 A IL40686 A IL 40686A IL 4068672 A IL4068672 A IL 4068672A IL 40686 A IL40686 A IL 40686A
Authority
IL
Israel
Prior art keywords
triazin
imidazo
ones
amino
preparation
Prior art date
Application number
IL40686A
Other languages
English (en)
Other versions
IL40686A0 (en
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of IL40686A0 publication Critical patent/IL40686A0/xx
Publication of IL40686A publication Critical patent/IL40686A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL40686A 1971-11-19 1972-10-27 2-amino-imidazo(5,1-f)-as-triazin-4(3h)-ones,their preparation and pharmaceutical compositions containing them IL40686A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions

Publications (2)

Publication Number Publication Date
IL40686A0 IL40686A0 (en) 1972-12-29
IL40686A true IL40686A (en) 1975-12-31

Family

ID=10468856

Family Applications (1)

Application Number Title Priority Date Filing Date
IL40686A IL40686A (en) 1971-11-19 1972-10-27 2-amino-imidazo(5,1-f)-as-triazin-4(3h)-ones,their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US3840537A (enExample)
JP (1) JPS563873B2 (enExample)
AT (1) AT321923B (enExample)
AU (1) AU472127B2 (enExample)
BE (1) BE791025A (enExample)
CA (1) CA990292A (enExample)
CH (1) CH594671A5 (enExample)
DE (1) DE2255172A1 (enExample)
DK (1) DK138691B (enExample)
ES (1) ES408736A1 (enExample)
FR (1) FR2160407B1 (enExample)
GB (1) GB1400999A (enExample)
IE (1) IE37046B1 (enExample)
IL (1) IL40686A (enExample)
NL (1) NL7215646A (enExample)
PH (1) PH9669A (enExample)
SE (1) SE402915B (enExample)
ZA (1) ZA727532B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DE2314488C3 (de) * 1973-03-23 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 8-(2,6-Dichlorphenyl)-7-(4-chlorphenyl)-5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazin, Verfahren zu dessen Herstellung und dieses enthaltene Arzneimittel
DE2335193A1 (de) * 1973-07-11 1975-01-30 Hoechst Ag Bis-triazinobenzimidazole und ihre herstellung
US4107307A (en) * 1977-02-03 1978-08-15 American Cyanamid Company Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
USRE30511E (en) * 1977-02-03 1981-02-10 American Cyanamid Company Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
US4107308A (en) * 1977-10-18 1978-08-15 American Cyanamid Company Imidazo[1,5-d]-as-triazines
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
HU187474B (en) * 1981-11-18 1986-01-28 Gyogyszerkutato Intezet,Hu Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives
US4395547A (en) * 1982-02-10 1983-07-26 American Cyanamid Co. Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
HU227841B1 (en) 1997-11-12 2012-05-02 Bayer Pharma AG 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
CA2341488A1 (en) 1998-08-26 2000-03-09 Smithkline Beecham Corporation Therapies for treating pulmonary diseases
PL200923B1 (pl) 1999-08-21 2009-02-27 Nycomed Gmbh Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu
AU2002314044B2 (en) * 2001-05-09 2006-09-21 Bayer Healthcare Ag Novel use of 2-phenyl-substituted imidazotriazinones
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
GB0113344D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
DE10135815A1 (de) 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US7462614B2 (en) * 2003-04-01 2008-12-09 Smithkline Beecham Corporation Imidazotriazine compounds
MXPA06011423A (es) 2004-04-02 2007-01-23 Osi Pharm Inc Inhibidores de proteina cinasa heterobiciclica sustituida en el anillo 6,6-biciclico.
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
CA2623657A1 (en) * 2005-09-29 2007-04-12 Bayer Healthcare Ag Pde inhibitors and combinations thereof for the treatment of urological disorders
CA2630271C (en) * 2005-11-17 2014-04-08 Osi Pharmaceuticals, Inc. Fused bicyclic mtor inhibitors
JP2010532319A (ja) * 2007-06-13 2010-10-07 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 聴覚障害の処置用のｐｄｅ阻害剤
EP2421837A1 (en) 2009-04-20 2012-02-29 OSI Pharmaceuticals, LLC Preparation of c-pyrazine-methylamines
CN103374002B (zh) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 磷酸二酯酶-5抑制剂
JP2018508555A (ja) * 2015-03-16 2018-03-29 大日本住友製薬株式会社 二環性イミダゾロ誘導体
WO2017000276A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
WO2017204316A1 (ja) * 2016-05-27 2017-11-30 塩野義製薬株式会社 ５－オキソ－１，２，４－トリアジン誘導体およびその医薬組成物

Also Published As

Publication number Publication date
AU472127B2 (en) 1976-05-20
FR2160407B1 (enExample) 1975-10-17
US3840537A (en) 1974-10-08
CH594671A5 (enExample) 1978-01-13
CA990292A (en) 1976-06-01
FR2160407A1 (enExample) 1973-06-29
ZA727532B (en) 1973-07-25
BE791025A (fr) 1973-05-07
DK138691B (da) 1978-10-16
SE402915B (sv) 1978-07-24
DE2255172A1 (de) 1973-05-24
DK138691C (enExample) 1979-03-26
IL40686A0 (en) 1972-12-29
JPS4857993A (enExample) 1973-08-14
IE37046L (en) 1973-05-19
AT321923B (de) 1975-04-25
AU4819172A (en) 1974-05-16
JPS563873B2 (enExample) 1981-01-27
GB1400999A (en) 1975-07-16
PH9669A (en) 1976-02-10
IE37046B1 (en) 1977-04-27
ES408736A1 (es) 1976-03-01
NL7215646A (enExample) 1973-05-22

Similar Documents

Publication Publication Date Title
IL38687A (en) Omega-imidazolyl-omega-phenoxy-alkanones,their preparation and pharmaceutical compositions containing them
IL40686A0 (en) Triazinone derivatives,their preparation and pharmaceutical compositions containing them
IL43872A (en) 2-amino-5-alkyl-imidazo-(5,1-f)-as-triazine derivatives, their preparation and pharmaceutical compositions containing them
IL43762A (en) 11,11-alkylidene-steroids their preparation and pharmaceutical compositions containing them
IL38705A0 (en) Novel pyridazinones,their preparation and pharmaceutical compositions containing them
IL40184A0 (en) 5-cinnamoyl-benzofurans,their preparation and pharmaceutical compositions containing them
IL39110A (en) Sulphamides,their preparation and pharmaceutical compositions containing them
IL39392A0 (en) Aminopyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL39845A0 (en) Novel quinazolinone derivatives,their preparation and pharmaceutical compositions containing them
IL40572A0 (en) Biphenylyl-butanols,their preparation and pharmaceutical compositions containing them
IL39178A (en) Gonadotropins having prolonged activity,their preparation and pharmaceutical compositions containing them
IL39851A (en) 1,2,3,4,4a,10b-hexahydro-phenanthridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL48790A0 (en) Novel hydroxy-pyrimidines,their preparation and pharmaceutical compositions containing them
GB1407477A (en) 11beta-alkoxy-estra-1,3,5-10-trienes processes for their preparation and compositions incorporating them
IL36743A (en) Phenylaminoalkanes,their preparation and pharmaceutical compositions containing them
IL41200A0 (en) Substituted 3-amino-prop-1-enes,their preparation and pharmaceutical compositions containing them
IL38593A (en) Substituted 2-arylamino-imidazoline-(2)derivatives,their preparation and pharmaceutical compositions containing them
IL41034A0 (en) Novel 6-aza-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them
IL40828A0 (en) Dibenzothiepin derivatives,their manufacture and pharmaceutical compositions containing them
IL36549A (en) Substituted imidazolines-(2),their preparation and pharmaceutical compositions containing them
IL40362A0 (en) Novel 4-oxo-4h-1-benzopyran and-thiabenzopyran derivatives,their preparation and pharmaceutical compositions containing them
IL37588A0 (en) Pyrimidoisoquinolines,their preparation and pharmaceutical compositions containing them
IL36536A (en) Substituted 1,2,4,5-tetrahydro-(3h)-3-benzazepines,their preparation and pharmaceutical compositions containing them
IL39355A0 (en) Androstan-17beta-yl-acrylonitrile derivatives,their preparation and pharmaceutical compositions containing them
IL38772A0 (en) Amino-anthracene derivatives,their manufacture and pharmaceutical compositions containing them